Aims & Scope
Current Radiopharmaceuticals publishes original research articles, letters, full-length/mini-reviews, drug clinical trial studies, and guest-edited issues on all aspects of research and development of radiolabelled compound preparations, covering studies related to nuclear medicine, molecular imaging, radiotherapy, neuroradiology, interventional radiology, investigative radiology, oncology, and basic research. The scope of the journal also covers the following areas, namely radio imaging techniques, computerized medical images and graphics, preparation and application of radionuclide compounds, and their diagnostic, investigative, and therapeutic use, including the incorporation of tracer methods used in scientific research and applications. Articles related to the resources on radiation research in the field of biology and biophysics are also included.
Chemical Abstracts Service/SciFinder, ChemWeb, CNKI Scholar, Dimensions, EBSCO, EMBASE, Emerging Sources Citation Index (ESCI) by Clarivate Analytics, ERA 2018, Genamics JournalSeek, Google Scholar, J-Gate, JournalTOCs, MediaFinder®-Standard Periodical Directory, MEDLINE/PubMed, Open Abstracts (I4OA), Norwegian Register, PubsHub, QOAM, Science Citation Index Expanded™ (SciSearch®), Scilit, Scopus, Suweco CZ, and Ulrich's Periodicals Directory.
Current Radiopharmaceuticals was launched in 2008 with the assistance of Dr. Sean L. Kitson who served as the Editor-in-Chief of the journal till 2021. The current Editor-in-Chief, Prof. Dr. Andrea Ciarmiello, took charge of the journal from June 2021.